Enteromedics Inc.

Patents = 45

Trademarks = 3

Forward Citations = 2,847

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

30 inventors (with patents filed for the assignee):

EnteroMedics Inc. is a medical device company that develops and commercializes innovative therapies to treat obesity and other gastrointestinal disorders. Their FDA-approved product, vBloc Neurometabolic Therapy, is designed to help patients with obesity regain control over their hunger signals, leading to sustained weight loss. EnteroMedics is dedicated to improving the lives of individuals struggling with obesity through groundbreaking medical solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com